4.2 Delivery optimization Systemic administration of GLP-1RAs reduces their availability in the retina and can lead to off-target effects, particularly gastrointestinal issues
Adverse Reactions Occurring at an Incidence of 5% or More Among VYVANSE Treated Patients with ADHD in Clinical Trials The most common adverse reactions (incidence 5% and at a rate at least twice placebo) reported in pediatric patients ages 6 to 17 years, and/or adults were anorexia, anxiety, decreased appetite, decreased weight, diarrhea, dizziness, dry mouth, irritability, insomnia, nausea, upper abdominal pain, and vomiting
Convenience and ease of use The patches are easy to apply and can be worn throughout the day or night without disrupting your routine
This underscores why DermaVue's structured program includes a gradual tapering protocol and metabolic maintenance phase
It treats the symptom, not the cause, and it does not help motion sickness